PPAR-γ AF-2 domain functions as a component of a ubiquitin-dependent degradation signal

Obesity

Volumn 17, Issue 4, 2009, Pages 665-673

  Kilroy, Gail E ^a   Zhang, Xiaoying ^a   Floyd, Z Elizabeth ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME; UBIQUITIN;

ADIPOCYTE; ANIMAL; ANIMAL MODEL; ARTICLE; CELL STRAIN 3T3; CYTOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; GLUCOSE; LIGANDS; MICE; MODELS, ANIMAL; NIH 3T3 CELLS; PPAR GAMMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN;

EID: 63049133308     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.616     Document Type: Article

References (37)

1. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PRARγ. Annu Rev Biochem 2008;77:289-312.
2. Vidal-Puig A, Jimenez-Linan M, Lowell BB et al. Regulation of PPAR γ gene expression by nutrition and obesity in rodents. J Clin Invest 1996;97:2553-2561.
3. Hummasti S, Tontonoz P. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Mol Endocrinol 2006;20:1261-1275.
4. Medina-Gomez G, Gray SL, Yetukuri L et al. PPAR γ 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 2007;3:e64.
5. Kubota N, Terauchi Y, Miki H et al. PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609.
6. Miles PD, Barak Y, He W, Evans RM, Olefsky JM: Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. J Clin Invest 2000;105: 287-292.
7. Miles PD, Barak Y, Evans RM, Olefsky JM. Effect of heterozygous PPARγ deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding. Am J Physiol Endocrinol Metab 2003;284:E618-E626.
8. γ. J Biol Chem 2007;282:29946-29957.
9. Rieusset J, Seydoux J, Anghel SI et al. Altered growth in male peroxisome proliferator-actlvated receptor γ (PPARγ) heterozygous mice: involvement of PPARγ in a negative feedback regulation of growth hormone action. Mol Endocrinol 2004;18:2363-2377.
10. He W, Barak Y, Hevener A et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003;100:15712-15717.
11. Jones JR, Barrick C, Kim KA et al. Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2005;102:6207-6212.
12. Hauser S, Adelmant G, Sarraf P et al. Degradation of the peroxisome proliferator-actlvated receptor γ is linked to ligand-dependent activation. J Biol Chem 2000;275:18527-18533.
13. Floyd ZE, Stephens JM. Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes. J Biol Chem 2002;277:4062-4068.
14. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM. Interferon-γ- Induced regulation of peroxisome proliferator-actlvated receptor γ and STATs in adipocytes. J Biol Chem 2001;276:7062-7068.
15. Keracher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 2006;22: 159-180.
16. Floyd ZE, Stephens JM. Control of peroxisome proliferator-activated receptor γ2 stability and activity by SUMOylation. Obes Res 2004; 12: 921-928.
17. Herahko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479.
18. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP. Regulation of transcriptional activation domain function by ubiquitin. Science 2001;293:1651-1653.
19. Salghetti SE, Muratani M, Wijnen H, Futcher B, Tansey WP. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc Natl Acad Sci USA 2000;97: 3118-3123.
20. Catalano PM, Nizielski SE, Shao J et al. Downregulated IRS-1 and PPARγ in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002;282: E522-E533.
21. Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-37734.
22. Kisselev AF, Callard A, Goldberg AL. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 2006;281:8582-8590.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
24. Yang Y, Kitagaki J, Dai RM et al. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res 2007;67:9472-9481.
25. Finley D, Sadis S, Monia BP et al. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol Cell Biol 1994;14:5501-5509.
26. Hodgins RR, Ellison KS, Ellison MJ. Expression of a ubiquitin derivative that conjugates to protein irreversibly produces phenotypes consistent with a ubiquitin deficiency. J Biol Chem 1992;267:8807-8812.
27. Pickart CM. Back to the future with ubiquitin. Cell 2004;116:181-190.
28. Rosenberg-Hasson Y, Bercovich Z, Ciechanover A, Kahana C. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur J Biochem 1989;185:469-474.
29. Camp HS, Li O, Wise SC et al. Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone. Diabetes 2000;49:539-547.
30. Muratani M, Tansey WP. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 2003;4:192-201.
31. Nawaz Z, O'Malley BW. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 2004;18:493-499.
32. Li X, Lonard DM, Jung SY et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGγ proteasome. Cell 2006;124:381-392.
33. Zhou P. REGγ: a shortcut to destruction. Cell 2006;124:256-257.
34. Koutnikova H, Cock TA, Watanabe M et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR γ hypomorphic mice. Proc Natl Acad Sci USA 2003;100: 14457-14462.
35. Medina-Gomez G, Virtue S, Lelliott C et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-γ2 isoform. Diabetes 2005;54:1706-1716.
36. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferator-activated receptor a (PPARα) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J Biol Chem 2002;277: 37254-37259.
37. Genini D, Catapano CV. Block of nuclear receptor ubiquitination. A mechanism of ligand-dependent control of peroxisome proliferator-activated receptor delta activity. J Biol Chem 2007;282:11776-11785.